Decreasing medication does not equal more risks for people with rheumatoid arthritis in remission
Sunday, November 11, 2012 - 20:00
in Health & Medicine
Extending the time between doses, or tapering, TNF-inhibitor drugs in people with rheumatoid arthritis in remission can be done in some patients without significantly increasing disease activity or impairing joint function, according to new research findings.